Compare Harley-Davidson Inc (HOG) vs Medpace Holdings Inc (MEDP) Price & Performance

Harley-Davidson (HOG) trades at $25.98, down 0.46% on the day, with a bullish technical signal from moving averages but mixed oscillators. Recent Q2 2026 earnings beat estimates at $0.75 per share versus $0.645 expected, though revenue declined year-over-year. The company raised full-year guidance, citing strong North American retail sales and cost-cutting initiatives under its 'Back to the Bricks' strategy, while returning Revolution Max engine production to the U.S.

The stock presents a value opportunity with a low P/E of 14.84 and P/S of 0.72, but faces headwinds from declining revenue and net margins. Analyst consensus is mixed with a $26 price target near the current price, indicating limited near-term upside. Key risks include competitive pressures, raw material cost inflation, and execution of the turnaround plan amid weakening profitability trends.

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.